COM:CRINETICS
Crinetics Pharmaceuticals
- Stock
Last Close
57.03
22/11 21:00
Market Cap
4.01B
Beta: -
Volume Today
1.02M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|
average inventory | 119.50K - | 70.50K 41.00% | -689K 1,077.30% | -1.61M 133.02% | 3.12M 294.30% | 4.04M 29.38% | |||
average payables | 371.50K - | 929.50K 150.20% | 3.48M 274.07% | 5.54M 59.42% | 7.03M 26.79% | 7.68M 9.21% | 6.72M 12.51% | ||
average receivables | 403K - | 1.16M 187.59% | 1.48M 27.78% | 1.61M 8.41% | 1.93M 20.27% | 2.23M 15.33% | 5.89M 164.39% | ||
book value per share | -0.45 - | -1.08 142.13% | -3.57 230.07% | -3.88 8.60% | -5.50 41.88% | -7.16 30.09% | -8.45 17.97% | 9.28 209.88% | |
capex per share | -0.01 - | -0.02 60% | -0.09 298.17% | -0.02 76.67% | -0.01 69.98% | -0.01 85.69% | -0.03 180.84% | -0.08 153.41% | |
capex to depreciation | -2.07 - | -2.38 15.00% | -2.25 5.33% | -0.55 75.33% | -0.20 64.63% | -0.47 141.02% | -1.68 256.25% | -4.27 153.44% | |
capex to operating cash flow | 0.03 - | 0.03 7.70% | 0.05 69.69% | 0.01 80.51% | 0.00 71.73% | 0.00 64.13% | 0.01 192.06% | 0.03 96.10% | |
capex to revenue | -0.32 - | -0.15 53.92% | -0.44 193.40% | -0.41 5.45% | -2.62 535.23% | -0.40 84.56% | -0.35 13.57% | -1.17 234.17% | |
cash per share | 0.88 - | 1.02 16.79% | 13.50 1,219.81% | 4.90 63.71% | 5.61 14.60% | 8.68 54.70% | 6.43 25.90% | 9.62 49.51% | |
days of inventory on hand | |||||||||
days payables outstanding | 2.18K - | ||||||||
days sales outstanding | 44.62 - | 131.01 193.62% | 238.12 81.76% | 421.60 77.05% | 9.42K 2,135.09% | 687.00 92.71% | 186.85 72.80% | 850.51 355.18% | |
debt to assets | 0.02 - | 0.04 - | 0.02 41.17% | 0.01 59.98% | 0.01 34.37% | 0.01 14.28% | |||
debt to equity | -0.03 - | -0.05 - | -0.02 53.67% | -0.01 53.37% | -0.00 58.73% | 0.01 267.96% | |||
dividend yield | |||||||||
earnings yield | -0.02 - | -0.03 52.13% | -0.07 176.61% | -0.08 9.67% | -0.17 107.67% | -0.10 42.38% | -0.17 72.05% | -0.10 38.25% | |
enterprise value | 328.21M - | 325.96M 0.69% | 319.17M 2.08% | 571.07M 78.93% | 340.55M 40.37% | 894.35M 162.62% | 920.62M 2.94% | 2.06B 124.09% | |
enterprise value over ebitda | -55.48 - | -36.13 34.87% | -11.12 69.23% | -10.61 4.57% | -4.54 57.17% | -8.30 82.76% | -5.48 33.96% | -9.31 69.84% | |
ev to operating cash flow | -60.02 - | -34.39 42.71% | -16.40 52.30% | -12.31 24.93% | -5.49 55.41% | -10.10 83.88% | -7.99 20.84% | -12.40 55.23% | |
ev to sales | 557.24 - | 159.39 71.40% | 131.45 17.53% | 478.69 264.15% | 4.80K 902.00% | 829.63 82.70% | 194.35 76.57% | 514.08 164.52% | |
free cash flow per share | -0.41 - | -0.70 72.91% | -1.69 139.72% | -1.94 14.74% | -2.04 5.38% | -2.32 13.36% | -2.25 2.94% | -2.94 30.98% | |
free cash flow yield | -0.02 - | -0.03 72.91% | -0.06 95.92% | -0.08 37.15% | -0.14 87.39% | -0.08 43.70% | -0.12 50.68% | -0.08 32.63% | |
graham net net | -0.47 - | -1.14 141.40% | 12.67 1,212.64% | 4.36 65.56% | 5.15 18.02% | 8.33 61.75% | 5.78 30.63% | 8.08 39.85% | |
graham number | 2.09 - | 4.01 91.93% | 13.40 234.23% | 13.37 0.18% | 17.22 28.72% | 21.15 22.86% | 24.19 14.34% | 27.78 14.86% | |
income quality | 0.91 - | 1.04 13.95% | 0.72 30.67% | 0.92 28.18% | 0.84 8.64% | 0.82 2.06% | 0.70 14.60% | 0.78 10.30% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -549.45 - | -1.14K 107.64% | -38.89 - | ||||||
interest debt per share | 0.02 - | 0.00 96.41% | 0.20 - | 0.13 34.27% | 0.08 39.33% | 0.12 52.52% | 0.07 41.09% | ||
inventory turnover | |||||||||
invested capital | -0.03 - | -0.05 - | -0.02 53.67% | -0.01 53.37% | -0.00 58.73% | 0.01 267.96% | |||
market cap | 340.15M - | 340.15M 0% | 364.14M 7.05% | 606.55M 66.57% | 429.62M 29.17% | 1.09B 154.17% | 951.27M 12.88% | 2.07B 117.20% | |
net current asset value | -6.44M - | -15.46M 140.06% | 155.49M 1,106.10% | 110.10M 29.19% | 162.97M 48.02% | 325.65M 99.83% | 309.34M 5.01% | 477.91M 54.49% | |
net debt to ebitda | 2.02 - | 1.57 22.05% | 1.57 0.43% | 0.66 57.93% | 1.19 80.32% | 1.83 54.40% | 0.18 90.05% | 0.01 92.16% | |
net income per share | -0.43 - | -0.66 52.13% | -2.23 238.45% | -2.05 8.25% | -2.39 16.79% | -2.78 16.02% | -3.08 10.83% | -3.69 20.06% | |
operating cash flow per share | -0.39 - | -0.68 73.35% | -1.60 134.64% | -1.92 19.71% | -2.04 6.18% | -2.30 13.14% | -2.22 3.84% | -2.86 29.22% | |
payables turnover | 0.17 - | ||||||||
receivables turnover | 8.18 - | 2.79 65.94% | 1.53 44.98% | 0.87 43.52% | 0.04 95.53% | 0.53 1,271.64% | 1.95 267.67% | 0.43 78.03% | |
research and ddevelopement to revenue | 8.66 - | 4.51 47.86% | 10.08 123.30% | 34.79 245.08% | 802.79 2,207.44% | 78.16 90.26% | 27.49 64.83% | 41.72 51.76% | |
return on tangible assets | -0.48 - | -0.59 22.88% | -0.16 73.06% | -0.38 140.19% | -0.40 4.54% | -0.30 23.46% | -0.45 49.39% | -0.34 25.66% | |
revenue per share | 0.04 - | 0.15 247.20% | 0.20 35.71% | 0.05 75.32% | 0.00 95.27% | 0.03 1,102.77% | 0.09 224.92% | 0.07 24.17% | |
roe | 0.97 - | 0.61 37.17% | 0.63 2.54% | 0.53 15.51% | 0.43 17.68% | 0.39 10.81% | 0.36 6.06% | -0.40 209.26% | |
roic | 1.01 - | 0.60 40.13% | 0.70 15.84% | 0.63 10.27% | 0.46 26.27% | 0.40 14.42% | 0.38 5.12% | -0.38 200.07% | |
sales general and administrative to revenue | 2.60 - | 0.95 63.57% | 2.74 189.25% | 11.33 313.18% | 253.89 2,140.46% | 22.75 91.04% | 8.95 60.66% | ||
shareholders equity per share | -0.45 - | -1.08 142.13% | -3.57 230.07% | -3.88 8.60% | -5.50 41.88% | -7.16 30.09% | -8.45 17.97% | 9.28 209.88% | |
stock based compensation to revenue | 0.46 - | 0.13 71.09% | 0.96 621.05% | 5.28 452.14% | 146.86 2,683.65% | 16.10 89.04% | 5.97 62.93% | ||
tangible asset value | -6.20M - | -15.02M 142.13% | 160.22M 1,166.60% | 117.14M 26.89% | 168.92M 44.20% | 331.94M 96.51% | 316.33M 4.70% | 539.11M 70.43% | |
tangible book value per share | -0.45 - | -1.08 142.13% | 13.20 1,319.11% | 4.85 63.28% | 5.55 14.49% | 8.64 55.67% | 6.09 29.54% | 9.28 52.56% | |
working capital | 11.47M - | 14.27M 24.34% | 158.76M 1,012.69% | 115.00M 27.56% | 167.00M 45.22% | 328.73M 96.84% | 317.46M 3.43% | 530.21M 67.02% |
All numbers in USD (except ratios and percentages)